Nanoviricides (FRA:NV3P) Cyclically Adjusted FCF per Share: €-1.15 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NV3P Nanoviricides Inc FRA:NV3P
35 GF Score
Price €1.27
View Full Analysis

What is Nanoviricides Cyclically Adjusted FCF per Share?

Nanoviricides FRA:NV3P +0.79% 35 Cyclically Adjusted FCF per Share is €-1.15 as of Mar. 2026. GuruFocus rates FRA:NV3P with a GF Score™ of 35/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Nanoviricides's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.077. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.15 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Nanoviricides was 15.60% per year. The lowest was -3.70% per year. And the median was 0.75% per year.

As of today (2026-08-01), Nanoviricides's current stock price is €1.27. Nanoviricides's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-1.15. Nanoviricides's Cyclically Adjusted Price-to-FCF of today is .


Nanoviricides  (FRA:NV3P) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Nanoviricides Cyclically Adjusted FCF per Share Related Terms


Nanoviricides Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Nanoviricides's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoviricides Cyclically Adjusted FCF per Share Chart

Nanoviricides Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.35 -2.78 -2.50 -2.00 -1.39

Nanoviricides Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.63 -1.39 -1.31 -1.25 -1.15

FRA:NV3P vs LITS, ESLA, LTRN: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Nanoviricides's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanoviricides Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoviricides's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Nanoviricides's Cyclically Adjusted Price-to-FCF falls into.


FRA:NV3P
35GF Score
Nanoviricides Inc FRA:NV3P
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoviricides Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nanoviricides's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.077/330.2130*330.2130
=-0.077

Current CPI (Mar. 2026) = 330.2130.

Nanoviricides Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.440 241.018 -0.603
201609 -0.689 241.428 -0.942
201612 -0.851 241.432 -1.164
201703 -0.658 243.801 -0.891
201706 -0.298 244.955 -0.402
201709 -0.421 246.819 -0.563
201712 -0.391 246.524 -0.524
201803 -0.362 249.554 -0.479
201806 -0.878 251.989 -1.151
201809 -0.247 252.439 -0.323
201812 -0.552 251.233 -0.726
201903 -0.496 254.202 -0.644
201906 -0.388 256.143 -0.500
201909 -0.340 256.759 -0.437
201912 -0.263 256.974 -0.338
202003 -0.333 258.115 -0.426
202006 -0.183 257.797 -0.234
202009 -0.184 260.280 -0.233
202012 -0.179 260.474 -0.227
202103 -0.119 264.877 -0.148
202106 -0.167 271.696 -0.203
202109 -0.055 274.310 -0.066
202112 -0.177 278.802 -0.210
202203 -0.133 287.504 -0.153
202206 -0.121 296.311 -0.135
202209 -0.094 296.808 -0.105
202212 -0.118 296.797 -0.131
202303 -0.144 301.836 -0.158
202306 -0.119 305.109 -0.129
202309 -0.094 307.789 -0.101
202312 -0.135 306.746 -0.145
202403 -0.155 312.332 -0.164
202406 -0.120 314.175 -0.126
202409 -0.174 315.301 -0.182
202412 -0.144 315.605 -0.151
202503 -0.115 319.799 -0.119
202506 -0.091 322.561 -0.093
202509 -0.084 324.800 -0.085
202512 -0.088 324.054 -0.090
202603 -0.077 330.213 -0.077

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-1.15 mean?
Nanoviricides (FRA:NV3P) has a Cyclically Adjusted FCF per Share of €-1.15 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nanoviricides and its competitors.
Is Nanoviricides' Cyclically Adjusted FCF per Share too high?
Nanoviricides' current Cyclically Adjusted FCF per Share is €-1.15. Overall, Nanoviricides has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' Cyclically Adjusted FCF per Share compare to LITS and ESLA?
Nanoviricides' Cyclically Adjusted FCF per Share of €-1.15 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Nanoviricides and its competitors. Nanoviricides's current Cyclically Adjusted FCF per Share is €-1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (FRA:NV3P) has a current Cyclically Adjusted FCF per Share of €-1.15. The current Cyclically Adjusted FCF per Share is €-1.15. Nanoviricides' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Nanoviricides (FRA:NV3P), the current Cyclically Adjusted FCF per Share is €-1.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanoviricides Business Description

Other Exchanges NNVC:USA
Address 1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
35GF Score

Get the complete analysis for FRA:NV3P

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.27
Price